---
title: Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in
  Adults over 70 years old
date: '2024-09-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39241195/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240907181832&v=2.18.0.post9+e462414
source: Blood
description: The advent of reduced-intensity conditioning regimens, improvements in
  graft-versus-host disease prophylaxis, and better supportive care have permitted
  increasing use of allogeneic hematopoietic cell transplantation (allo-HCT) in adults
  age ≥70 with AML. However, while potentially curative, non-relapse mortality and
  relapse represent the main causes of treatment failure, highlighting the importance
  of refining both patient selection and transplant strategies. At the same time,
  ...
disable_comments: true
---
The advent of reduced-intensity conditioning regimens, improvements in graft-versus-host disease prophylaxis, and better supportive care have permitted increasing use of allogeneic hematopoietic cell transplantation (allo-HCT) in adults age ≥70 with AML. However, while potentially curative, non-relapse mortality and relapse represent the main causes of treatment failure, highlighting the importance of refining both patient selection and transplant strategies. At the same time, ...